1,036 results on '"El-Rifai, Wael"'
Search Results
2. Fibroblast growth factor receptor-4 mediates activation of Nuclear Factor Erythroid 2-Related Factor-2 in gastric tumorigenesis
3. Chronic Gastroesophageal Reflux Dysregulates Proteostasis in Esophageal Epithelial Cells
4. Correction: Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells
5. Smoking induces WEE1 expression to promote docetaxel resistance in esophageal adenocarcinoma
6. SOX9 Modulates the Transformation of Gastric Stem Cells Through Biased Symmetric Cell Division
7. Protein adduction causes non-mutational inhibition of p53 tumor suppressor
8. CDK1 bridges NF-κB and β-catenin signaling in response to H. pylori infection in gastric tumorigenesis
9. Induction of Fibroblast Growth Factor Receptor 4 by Helicobacter pylori via Signal Transducer and Activator of Transcription 3 With a Feedforward Activation Loop Involving SRC Signaling in Gastric Cancer
10. Helicobacter pylori–induced RASAL2 Through Activation of Nuclear Factor-κB Promotes Gastric Tumorigenesis via β-catenin Signaling Axis
11. miRNAs as novel immunoregulators in cancer
12. Esophageal adenocarcinoma models: a closer look.
13. A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer
14. Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics
15. APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett’s-associated esophageal adenocarcinomas
16. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments
17. Data from Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
18. Targeting SMAD3 Improves Response to Oxaliplatin in Esophageal Adenocarcinoma Models by Impeding DNA Repair
19. Activation of NRF2 by APE1/REF1 is redox-dependent in Barrett's related esophageal adenocarcinoma cells
20. The antioxidant response in Barrett's tumorigenesis: A double-edged sword
21. Silencing of miR490–3p by H. pylori activates DARPP-32 and induces resistance to gefitinib
22. Targeting SOX2 Protein with Peptide Aptamers for Therapeutic Gains against Esophageal Squamous Cell Carcinoma
23. PRDX2 protects against oxidative stress induced by H. pylori and promotes resistance to cisplatin in gastric cancer
24. NF-kB-dependent activation of STAT3 by H. pylori is suppressed by TFF1
25. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy
26. Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy
27. Correction: Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy
28. NRF2 antioxidant response protects against acidic bile salts-induced oxidative stress and DNA damage in esophageal cells
29. Integrated Analysis of Mouse and Human Gastric Neoplasms Identifies Conserved microRNA Networks in Gastric Carcinogenesis
30. Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1
31. Correction: Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells
32. Fibroblast growth factor receptor-4 mediates activation of Nuclear Factor Erythroid 2-Related Factor-2 in gastric tumorigenesis
33. Activation of IGF1R by DARPP-32 promotes STAT3 signaling in gastric cancer cells
34. Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer
35. Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance
36. Correction to: Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance
37. Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma.
38. Abstract 1379 CDK1-SOX9 axis contributes to chemotherapy resistance in gastric cancer
39. Exposure of Barrett’s and esophageal adenocarcinoma cells to bile acids activates EGFR–STAT3 signaling axis via induction of APE1
40. Helicobacter pylori pathogen regulates p14ARF tumor suppressor and autophagy in gastric epithelial cells
41. Abstract 3237: Dovitinib restricts EMT and promotes T cell recruitment to immune-desert gastric cancers via tumor-intrinsic IFN-γ signaling
42. Abstract 3964: APE1 protects SMAD3 against ROC1 ubiquitin mediated degradation in esophageal adenocarcinoma cells
43. Abstract 4776: NRF2 is overexpressed in esophageal adenocarcinoma and its targeting sensitizes tumor cells to cisplatin through induction of ferroptosis and apoptosis
44. Abstract 2592: Helicobacter pylori-induced FGFR4 mediates nuclear accumulation of NRF2 in gastric tumorigenesis
45. Abstract 1232: Gastroesophageal reflux disease promotes E-cadherin cleavage and activates EMT via APE1-redox function in esophageal adenocarcinoma
46. Abstract 5972: CDK1 bridges NF-kB and b-catenin signaling in response to H. pylori infection in gastric tumorigenesis
47. Data from Methylation of the HOXA10 Promoter Directs miR-196b-5p–Dependent Cell Proliferation and Invasion of Gastric Cancer Cells
48. Supplementary Table 1 from The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells
49. Supplementary Figure Legends 1-3, Table Legend 1 from The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells
50. Supplementary Figure 2 from The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.